ANGO
NASD AngioDynamics, Inc.$11.60 ↑ +0.02 (+0.17%) Trading Up from the previous close of $11.58
- YTD change
- -9.66%
- vs 20-day SMA
- -17.55%
- vs 200-day SMA
- -6.75%
Price ranges
Price & Performance
+1.12 (+10.71%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 63.7% away from all-time highs of $32.00
- ANGO is down 10% since the beginning of the year
- ANGO is down 1% over the past 12 months
- ANGO is down 25% over the past 1 month
- 3% of all ANGO investors are betting against ANGO
ANGO reads neutral: price sits below both the 20- and 200-day averages, the 12-month move is -1.2%.
- Previous minute
- +$0.00
- Last hour
- +$0.05
- Last 5 days
- +3.29%
- vs 8-day SMA
- -3.62%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
AngioDynamics, Inc. is a medical device company, which engages in the development, manufacturing, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The firm offers ablation systems, fluid management systems, vascular access, angiographic, drainage, thrombolytic, and venous products. It operates through the Med Tech and Med Device segments. The Med Tech segment consists of technology portfolio including Auryon, the thrombus management platform and NanoKnife. The Med Device segment focuses on core, venous, ports, and other oncology products. The company was founded by Howard S. Stern and Eamonn P. Hobbs on February 9, 1988 and is headquartered in Latham, NY.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
